Skip to main content

Table 2 Diagnoses and classification of rhino-conjunctivitis (RC) and asthma by treatment modality at baseline (B) and at follow-up (F) with an intension to treat approach N = 248

From: Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days

 

Grass pollen only N = 169

House dust mites(HDM)only N = 25

Grass and HDM mites N = 54

Full sample N = 248

P-value

B

F

B

F

B

F

B

F

RC diagnosis, ± classification

RC diagnosis

169

166

25

23

54

48

248

237

 

 No RC diagnosis

0

3

0

2

0

6

0

11

0,013 a

 Intermittent RC

7

57

4

8

4

18

15

83

 Persistent RC

162

109

21

15

50

30

233

154

Asthma diagnosis

 

Asthma diagnosis

81

70

12

8

28

24

121

102

< 0.001a

No asthma diagnosis

88

99

13

17

26

30

127

146

 Intermittent

29

27

6

3

7

8

42

38

 

 Mild Persistent

21

22

1

1

6

3

28

26

 Moderate Persistent

28

18

4

3

11

12

43

33

 Severe Persistent

3

3

1

1

4

1

8

5

Days with inconvenience last year mean (SD)

160.2 (105.1)

119.6 (118.5)

270.9 (102.8)

191.1 (137.6)

247.2 (134.0)

185.3 (142.8)

189.3 (119.9)

141.1 (123.4)

< 0.001b

Sick-days last year mean (SD), ‘median, min- max days’

3.49 (17.78) ´0, 0-220`

0.88 (3.04)´ 0, 0–22.5`

6.75 (13.72) ´0, 0-55`

4.00 (12.51) ´0, 0-55`

2.87 (6.05) ´0, 0-30`

0,87 (2.30) ´0, 0-10`

3.68 (15.58) ´0, 0-220`

1.19 (4.82) ´0, 0-55`

< 0.001b

HRQoL- scores mean (SD)

RQLQ*

3.12 (0.68)

2.01 (0.78)

3.21 (0.66)

2.34 (0.76)

2.61 (0.79)

1.83 (0,85)

3.02 (0.74)

2.00 (0.80)

< 0.001b

EQ-5D-score on days with no allergen exposure

0.98(0.06)

0.98 (0.07)

0.93 (0.13)

0.97 (0.08)

0.98 (0.05)

0.99 (0.04)

0.98 (0.07)

0.98 (0.07)

0.975

EQ-5D-score on days with allergen exposure

0.70 (0.18)

0.78 (0.15)

0.60 (0.30)

0.67 (0.27)

0.72 (0.18)

0.80 (0.15)

0.70 (0.20)

0.77 (0.17)

< 0.001b

15D-score on days with no allergen exposure

0.98 (0.03)

0.98 (0.04)

0.97 (0.05)

0.97 (0.05)

0.98 (0.03)

0.99 (0.02)

0.98 (0.03)

0.98 (0.04)

0.180

15D-score on days with allergen exposure

0.83 (0.08)

0.86 (0.08)

0.79 (0.09)

0.81 (0.11)

0.83 (0.08)

0.88 (0.07)

0.83 (0.08)

0.86 (0.08)

< 0.001b

  1. *Rhino-conjunctivitis Quality of Life Questionnaire, aSignificant difference (p < 0.05) from baseline to follow-up Fishers Exact x2 test, bsignificant difference (p < 0.05) from baseline to follow-up Wilcoxon signed-rank test.